Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2013

Date: November 15, 2013
Pages: 106
Price:
US$ 2,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: LB7D90FE7C1EN
Leaflet:

Download PDF Leaflet

Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2013
Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, “Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2013' provides data on the Left Ventricular Hypertrophy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Left Ventricular Hypertrophy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Left Ventricular Hypertrophy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
Left Ventricular Hypertrophy
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Left Ventricular Hypertrophy
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Left Ventricular Hypertrophy Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Novartis AG
Clinical Trial Overview of Novartis AG
Abbott Laboratories
Clinical Trial Overview of Abbott Laboratories
Sanofi
Clinical Trial Overview of Sanofi
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
AbbVie Inc.
Clinical Trial Overview of AbbVie Inc.
Clinical Trial Overview of Top Institutes / Government
National Heart, Lung, and Blood Institute
Clinical Trial Overview of National Heart, Lung, and Blood Institute
University of Dundee
Clinical Trial Overview of University of Dundee
Washington University School of Medicine
Clinical Trial Overview of Washington University School of Medicine
Medical University of Vienna
Clinical Trial Overview of Medical University of Vienna
Aarhus University
Clinical Trial Overview of Aarhus University
Wayne State University
Clinical Trial Overview of Wayne State University
Azienda Ospedaliera Universitaria San Martino
Clinical Trial Overview of Azienda Ospedaliera Universitaria San Martino
Wuhan General Hospital of Guangzhou Military Command
Clinical Trial Overview of Wuhan General Hospital of Guangzhou Military Command
Mustafa Kemal Universitesi
Clinical Trial Overview of Mustafa Kemal Universitesi
Kyoto University
Clinical Trial Overview of Kyoto University
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Left Ventricular Hypertrophy Therapeutics Market, Global, Clinical Trials by Zone, 2013
Left Ventricular Hypertrophy Therapeutics Market, Global, Clinical Trials by Top Countries, 2013
Left Ventricular Hypertrophy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, Europe, Top Five Countries, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, North America, Top Countries, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, Central and South America, Top Countries, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, BRIC Countries, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, G7 Countries, 2013
Left Ventricular Hypertrophy Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, E7 Countries, 2013
Left Ventricular Hypertrophy Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013
Left Ventricular Hypertrophy Therapeutics Market, Global, Clinical Trials by Phase, 2013
Left Ventricular Hypertrophy Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013
Left Ventricular Hypertrophy Therapeutics Market, Global, Clinical Trials by Trial Status, 2013
Left Ventricular Hypertrophy Therapeutics Market, Global, Terminated Clinical Trials, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
Left Ventricular Hypertrophy Therapeutics Clinical Trials, Global, Key Sponsors, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Dundee, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Wayne State University, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria San Martino, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Wuhan General Hospital of Guangzhou Military Command, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Mustafa Kemal Universitesi, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2013

LIST OF FIGURES

Left Ventricular Hypertrophy Therapeutics Market, Global, Clinical Trials by Zone (%), 2013
Left Ventricular Hypertrophy Therapeutics Market, Global, Clinical Trials by Top Countries, 2013
Left Ventricular Hypertrophy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, North America, Top Countries (%), 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, BRIC Countries (%), 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, G7 Countries (%), 2013
Left Ventricular Hypertrophy Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, E7 Countries (%), 2013
Left Ventricular Hypertrophy Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013
Left Ventricular Hypertrophy Therapeutics Market, Global, Clinical Trials by Phase (%), 2013
Left Ventricular Hypertrophy Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013
Left Ventricular Hypertrophy Therapeutics Market, Global, Clinical Trials by Trial Status, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
Left Ventricular Hypertrophy Therapeutics Clinical Trials, Global, Key Sponsors, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013
Left Ventricular Hypertrophy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013
GlobalData Methodology

Ask Your Question

Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2013
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: